Managing Side Effects of Newer Therapies for Acute Lymphoblastic Leukemia (ALL)
Search
Managing Side Effects of Newer Therapies for Acute Lymphoblastic Leukemia (ALL)
Array
Activity Info
This activity is the fourth and final module in a series of four educational activities on managing side effects of newer therapies for ALL. Dr. Brandon Hayes-Lattin from Oregon Health & Sciences University, discusses strategies to prevent, monitor, and manage VOD associated with CD22-directed ADC therapy.